Dr. Carly J. Worden (AKA Carly J. Paoli, for publication purposes), PharmD, MPH, is a health economist with over 10 years of experience in both the pharmaceutical and medical devices/diagnostics industries. Dr. Worden has more than a dozen peer-reviewed manuscripts in epidemiology, burden of disease, real-world outcomes and health economics. She is a guest lecturer for advanced health economic studies at both the University of California, San Francisco and the University of Southern California. Since beginning her work at Danaher in 2016, she has been an integral team member for the Beckman Coulter hematology therapeutic area as a key subject matter expert in sepsis, producing two peer-reviewed manuscripts and winning an award for Best Industry Poster at AACC (American Association of Clinical Chemistry) 2019.